Amgen to acquire Seattle biotech company Rodeo Therapeutics for $55M

Rodeo Therapeutics CEO Thong Le. (Accelerator Life Science Partners Photo) The news: Pharmaceutical giant Amgen

Read the full article at contacted.org...

Found and curated by

SMB

Comments

Popular posts from this blog

New Challenges to Operational Efficiencies Because of COVID Protocols

Becoming a Coach Trainer